BioLight Life Sciences Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0.02	0.22	0.12	0.06	0	0.03
Revenue Growth (YoY)	-91.25%	85.59%	87.30%	2000.00%	-90.32%	-
Gross Profit	0.02	0.22	0.12	0.06	0	0.03
Selling, General & Admin	8.64	6.66	6.25	6.86	6.27	6.66
Research & Development	4.66	3.67	4.52	3.53	4.34	3.99
Other Operating Expenses	-	-	-	-	-	0.77
Operating Expenses	13.29	10.34	10.77	10.39	10.61	11.42
Operating Income	-13.27	-10.12	-10.65	-10.32	-10.6	-11.39
Interest Expense	-0.06	-0.08	-0.08	-0.07	-0.02	-0.04
Interest & Investment Income	0.07	0.06	0.26	0.01	0.07	0.3
Earnings From Equity Investments	-0.36	-0.29	-0.39	-0.63	-0.28	-0.38
Currency Exchange Gain (Loss)	-0.31	-0.31	0.04	0.57	-0.88	-1.19
Other Non Operating Income (Expenses)	-0.17	-0.17	-0.96	0.3	-0.27	0.03
EBT Excluding Unusual Items	-14.09	-10.92	-11.77	-10.14	-11.98	-12.67
Gain (Loss) on Sale of Investments	-4.02	2.49	-15.72	1.45	10.07	-1.43
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.07
Pretax Income	-18.12	-8.42	-27.49	-8.69	-1.91	-14.04
Income Tax Expense	-	-	-	-	-1.57	0.14
Earnings From Continuing Operations	-18.12	-8.42	-27.49	-8.69	-0.34	-14.17
Earnings From Discontinued Operations	-	-	-	-	-	-0.92
Net Income to Company	-18.12	-8.42	-27.49	-8.69	-0.34	-15.09
Minority Interest in Earnings	4.07	1.28	1.47	0.84	0.72	1.7
Net Income	-14.05	-7.14	-26.02	-7.85	0.38	-13.38
Net Income to Common	-14.05	-7.14	-26.02	-7.85	0.38	-13.38
Shares Outstanding (Basic)	5	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5	5
Shares Change (YoY)	3.47%	0.29%	1.70%	-0.41%	0.94%	-
EPS (Basic)	-2.92	-1.53	-5.60	-1.72	0.08	-2.95
EPS (Diluted)	-2.92	-1.53	-5.60	-1.72	0.08	-2.95
Free Cash Flow	-	-11.02	-10.99	-9.57	-10.63	-13.49
Free Cash Flow Per Share	-	-2.37	-2.37	-2.10	-2.32	-2.97
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-63200.00%	-4619.64%	-9026.27%	-16384.13%	-353433.33%	-36751.61%
Profit Margin	-66895.24%	-3261.19%	-22050.85%	-12455.56%	12733.33%	-43167.74%
Free Cash Flow Margin	-	-5032.88%	-9315.25%	-15193.65%	-354333.33%	-43529.03%
EBITDA	-13.2	-10.06	-10.6	-9.73	-10.07	-10.84
D&A For EBITDA	0.07	0.06	0.05	0.59	0.53	0.56
EBIT	-13.27	-10.12	-10.65	-10.32	-10.6	-11.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.